Global Prescription Gastrointestinal Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 99

Published Date: 04 Jan 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Prescription Gastrointestinal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Prescription Gastrointestinal Drugs market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Hospital Pharmacies accounting for % of the Prescription Gastrointestinal Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Prescription Gastrointestinal Drugs include AstraZeneca, Axcan Pharmaceuticals, Eisai, GlaxoSmithKline, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Prescription Gastrointestinal Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Oral
    Topical

Market segment by Application can be divided into
    Hospital Pharmacies
    Online Pharmacies
    Retail Pharmacies

The key market players for global Prescription Gastrointestinal Drugs market are listed below:
    AstraZeneca
    Axcan Pharmaceuticals
    Eisai
    GlaxoSmithKline
    Merck
    Salix Pharmaceuticals

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prescription Gastrointestinal Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prescription Gastrointestinal Drugs, with price, sales, revenue and global market share of Prescription Gastrointestinal Drugs from 2019 to 2022.
Chapter 3, the Prescription Gastrointestinal Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Gastrointestinal Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Prescription Gastrointestinal Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prescription Gastrointestinal Drugs.
Chapter 13, 14, and 15, to describe Prescription Gastrointestinal Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Prescription Gastrointestinal Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Prescription Gastrointestinal Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Oral
        1.2.3 Topical
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Prescription Gastrointestinal Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharmacies
        1.3.4 Retail Pharmacies
    1.4 Global Prescription Gastrointestinal Drugs Market Size & Forecast
        1.4.1 Global Prescription Gastrointestinal Drugs Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Prescription Gastrointestinal Drugs Sales in Volume (2017-2028)
        1.4.3 Global Prescription Gastrointestinal Drugs Price (2017-2028)
    1.5 Global Prescription Gastrointestinal Drugs Production Capacity Analysis
        1.5.1 Global Prescription Gastrointestinal Drugs Total Production Capacity (2017-2028)
        1.5.2 Global Prescription Gastrointestinal Drugs Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Prescription Gastrointestinal Drugs Market Drivers
        1.6.2 Prescription Gastrointestinal Drugs Market Restraints
        1.6.3 Prescription Gastrointestinal Drugs Trends Analysis

2 Manufacturers Profiles
    2.1 AstraZeneca
        2.1.1 AstraZeneca Details
        2.1.2 AstraZeneca Major Business
        2.1.3 AstraZeneca Prescription Gastrointestinal Drugs Product and Services
        2.1.4 AstraZeneca Prescription Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Axcan Pharmaceuticals
        2.2.1 Axcan Pharmaceuticals Details
        2.2.2 Axcan Pharmaceuticals Major Business
        2.2.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
        2.2.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Eisai
        2.3.1 Eisai Details
        2.3.2 Eisai Major Business
        2.3.3 Eisai Prescription Gastrointestinal Drugs Product and Services
        2.3.4 Eisai Prescription Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 GlaxoSmithKline
        2.4.1 GlaxoSmithKline Details
        2.4.2 GlaxoSmithKline Major Business
        2.4.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Product and Services
        2.4.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Merck
        2.5.1 Merck Details
        2.5.2 Merck Major Business
        2.5.3 Merck Prescription Gastrointestinal Drugs Product and Services
        2.5.4 Merck Prescription Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Salix Pharmaceuticals
        2.6.1 Salix Pharmaceuticals Details
        2.6.2 Salix Pharmaceuticals Major Business
        2.6.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
        2.6.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Prescription Gastrointestinal Drugs Breakdown Data by Manufacturer
    3.1 Global Prescription Gastrointestinal Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Prescription Gastrointestinal Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Prescription Gastrointestinal Drugs
    3.4 Market Concentration Rate
        3.4.1 Top 3 Prescription Gastrointestinal Drugs Manufacturer Market Share in 2021
        3.4.2 Top 6 Prescription Gastrointestinal Drugs Manufacturer Market Share in 2021
    3.5 Global Prescription Gastrointestinal Drugs Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Prescription Gastrointestinal Drugs Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Prescription Gastrointestinal Drugs Market Size by Region
        4.1.1 Global Prescription Gastrointestinal Drugs Sales in Volume by Region (2017-2028)
        4.1.2 Global Prescription Gastrointestinal Drugs Revenue by Region (2017-2028)
    4.2 North America Prescription Gastrointestinal Drugs Revenue (2017-2028)
    4.3 Europe Prescription Gastrointestinal Drugs Revenue (2017-2028)
    4.4 Asia-Pacific Prescription Gastrointestinal Drugs Revenue (2017-2028)
    4.5 South America Prescription Gastrointestinal Drugs Revenue (2017-2028)
    4.6 Middle East and Africa Prescription Gastrointestinal Drugs Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Prescription Gastrointestinal Drugs Sales in Volume by Type (2017-2028)
    5.2 Global Prescription Gastrointestinal Drugs Revenue by Type (2017-2028)
    5.3 Global Prescription Gastrointestinal Drugs Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Prescription Gastrointestinal Drugs Sales in Volume by Application (2017-2028)
    6.2 Global Prescription Gastrointestinal Drugs Revenue by Application (2017-2028)
    6.3 Global Prescription Gastrointestinal Drugs Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Prescription Gastrointestinal Drugs Sales by Type (2017-2028)
    7.2 North America Prescription Gastrointestinal Drugs Sales by Application (2017-2028)
    7.3 North America Prescription Gastrointestinal Drugs Market Size by Country
        7.3.1 North America Prescription Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
        7.3.2 North America Prescription Gastrointestinal Drugs Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Prescription Gastrointestinal Drugs Sales by Type (2017-2028)
    8.2 Europe Prescription Gastrointestinal Drugs Sales by Application (2017-2028)
    8.3 Europe Prescription Gastrointestinal Drugs Market Size by Country
        8.3.1 Europe Prescription Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
        8.3.2 Europe Prescription Gastrointestinal Drugs Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Prescription Gastrointestinal Drugs Sales by Type (2017-2028)
    9.2 Asia-Pacific Prescription Gastrointestinal Drugs Sales by Application (2017-2028)
    9.3 Asia-Pacific Prescription Gastrointestinal Drugs Market Size by Region
        9.3.1 Asia-Pacific Prescription Gastrointestinal Drugs Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Prescription Gastrointestinal Drugs Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Prescription Gastrointestinal Drugs Sales by Type (2017-2028)
    10.2 South America Prescription Gastrointestinal Drugs Sales by Application (2017-2028)
    10.3 South America Prescription Gastrointestinal Drugs Market Size by Country
        10.3.1 South America Prescription Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
        10.3.2 South America Prescription Gastrointestinal Drugs Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Prescription Gastrointestinal Drugs Sales by Type (2017-2028)
    11.2 Middle East & Africa Prescription Gastrointestinal Drugs Sales by Application (2017-2028)
    11.3 Middle East & Africa Prescription Gastrointestinal Drugs Market Size by Country
        11.3.1 Middle East & Africa Prescription Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Prescription Gastrointestinal Drugs Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Prescription Gastrointestinal Drugs and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Prescription Gastrointestinal Drugs
    12.3 Prescription Gastrointestinal Drugs Production Process
    12.4 Prescription Gastrointestinal Drugs Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Prescription Gastrointestinal Drugs Typical Distributors
    13.3 Prescription Gastrointestinal Drugs Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Prescription Gastrointestinal Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Prescription Gastrointestinal Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 4. AstraZeneca Major Business
    Table 5. AstraZeneca Prescription Gastrointestinal Drugs Product and Services
    Table 6. AstraZeneca Prescription Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Axcan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 8. Axcan Pharmaceuticals Major Business
    Table 9. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
    Table 10. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Eisai Basic Information, Manufacturing Base and Competitors
    Table 12. Eisai Major Business
    Table 13. Eisai Prescription Gastrointestinal Drugs Product and Services
    Table 14. Eisai Prescription Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 16. GlaxoSmithKline Major Business
    Table 17. GlaxoSmithKline Prescription Gastrointestinal Drugs Product and Services
    Table 18. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Merck Basic Information, Manufacturing Base and Competitors
    Table 20. Merck Major Business
    Table 21. Merck Prescription Gastrointestinal Drugs Product and Services
    Table 22. Merck Prescription Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 24. Salix Pharmaceuticals Major Business
    Table 25. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
    Table 26. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Global Prescription Gastrointestinal Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
    Table 28. Global Prescription Gastrointestinal Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 29. Market Position of Manufacturers in Prescription Gastrointestinal Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 30. Global Prescription Gastrointestinal Drugs Production Capacity by Company, (K Units): 2020 VS 2021
    Table 31. Head Office and Prescription Gastrointestinal Drugs Production Site of Key Manufacturer
    Table 32. Prescription Gastrointestinal Drugs New Entrant and Capacity Expansion Plans
    Table 33. Prescription Gastrointestinal Drugs Mergers & Acquisitions in the Past Five Years
    Table 34. Global Prescription Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
    Table 35. Global Prescription Gastrointestinal Drugs Sales by Region (2023-2028) & (K Units)
    Table 36. Global Prescription Gastrointestinal Drugs Revenue by Region (2017-2022) & (USD Million)
    Table 37. Global Prescription Gastrointestinal Drugs Revenue by Region (2023-2028) & (USD Million)
    Table 38. Global Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
    Table 39. Global Prescription Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
    Table 40. Global Prescription Gastrointestinal Drugs Revenue by Type (2017-2022) & (USD Million)
    Table 41. Global Prescription Gastrointestinal Drugs Revenue by Type (2023-2028) & (USD Million)
    Table 42. Global Prescription Gastrointestinal Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 43. Global Prescription Gastrointestinal Drugs Price by Type (2023-2028) & (USD/Unit)
    Table 44. Global Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
    Table 45. Global Prescription Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
    Table 46. Global Prescription Gastrointestinal Drugs Revenue by Application (2017-2022) & (USD Million)
    Table 47. Global Prescription Gastrointestinal Drugs Revenue by Application (2023-2028) & (USD Million)
    Table 48. Global Prescription Gastrointestinal Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. Global Prescription Gastrointestinal Drugs Price by Application (2023-2028) & (USD/Unit)
    Table 50. North America Prescription Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
    Table 51. North America Prescription Gastrointestinal Drugs Sales by Country (2023-2028) & (K Units)
    Table 52. North America Prescription Gastrointestinal Drugs Revenue by Country (2017-2022) & (USD Million)
    Table 53. North America Prescription Gastrointestinal Drugs Revenue by Country (2023-2028) & (USD Million)
    Table 54. North America Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
    Table 55. North America Prescription Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
    Table 56. North America Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
    Table 57. North America Prescription Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
    Table 58. Europe Prescription Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
    Table 59. Europe Prescription Gastrointestinal Drugs Sales by Country (2023-2028) & (K Units)
    Table 60. Europe Prescription Gastrointestinal Drugs Revenue by Country (2017-2022) & (USD Million)
    Table 61. Europe Prescription Gastrointestinal Drugs Revenue by Country (2023-2028) & (USD Million)
    Table 62. Europe Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
    Table 63. Europe Prescription Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
    Table 64. Europe Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Prescription Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
    Table 66. Asia-Pacific Prescription Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
    Table 67. Asia-Pacific Prescription Gastrointestinal Drugs Sales by Region (2023-2028) & (K Units)
    Table 68. Asia-Pacific Prescription Gastrointestinal Drugs Revenue by Region (2017-2022) & (USD Million)
    Table 69. Asia-Pacific Prescription Gastrointestinal Drugs Revenue by Region (2023-2028) & (USD Million)
    Table 70. Asia-Pacific Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
    Table 71. Asia-Pacific Prescription Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
    Table 72. Asia-Pacific Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
    Table 73. Asia-Pacific Prescription Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
    Table 74. South America Prescription Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
    Table 75. South America Prescription Gastrointestinal Drugs Sales by Country (2023-2028) & (K Units)
    Table 76. South America Prescription Gastrointestinal Drugs Revenue by Country (2017-2022) & (USD Million)
    Table 77. South America Prescription Gastrointestinal Drugs Revenue by Country (2023-2028) & (USD Million)
    Table 78. South America Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
    Table 79. South America Prescription Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
    Table 80. South America Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
    Table 81. South America Prescription Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
    Table 82. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
    Table 83. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Region (2023-2028) & (K Units)
    Table 84. Middle East & Africa Prescription Gastrointestinal Drugs Revenue by Region (2017-2022) & (USD Million)
    Table 85. Middle East & Africa Prescription Gastrointestinal Drugs Revenue by Region (2023-2028) & (USD Million)
    Table 86. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
    Table 87. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
    Table 88. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
    Table 89. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
    Table 90. Prescription Gastrointestinal Drugs Raw Material
    Table 91. Key Manufacturers of Prescription Gastrointestinal Drugs Raw Materials
    Table 92. Direct Channel Pros & Cons
    Table 93. Indirect Channel Pros & Cons
    Table 94. Prescription Gastrointestinal Drugs Typical Distributors
    Table 95. Prescription Gastrointestinal Drugs Typical Customers
List of Figures
    Figure 1. Prescription Gastrointestinal Drugs Picture
    Figure 2. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type in 2021
    Figure 3. Oral
    Figure 4. Topical
    Figure 5. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application in 2021
    Figure 6. Hospital Pharmacies
    Figure 7. Online Pharmacies
    Figure 8. Retail Pharmacies
    Figure 9. Global Prescription Gastrointestinal Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
    Figure 10. Global Prescription Gastrointestinal Drugs Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Prescription Gastrointestinal Drugs Sales (2017-2028) & (K Units)
    Figure 12. Global Prescription Gastrointestinal Drugs Price (2017-2028) & (USD/Unit)
    Figure 13. Global Prescription Gastrointestinal Drugs Production Capacity (2017-2028) & (K Units)
    Figure 14. Global Prescription Gastrointestinal Drugs Production Capacity by Geographic Region: 2022 VS 2028
    Figure 15. Prescription Gastrointestinal Drugs Market Drivers
    Figure 16. Prescription Gastrointestinal Drugs Market Restraints
    Figure 17. Prescription Gastrointestinal Drugs Market Trends
    Figure 18. Global Prescription Gastrointestinal Drugs Sales Market Share by Manufacturer in 2021
    Figure 19. Global Prescription Gastrointestinal Drugs Revenue Market Share by Manufacturer in 2021
    Figure 20. Prescription Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 21. Top 3 Prescription Gastrointestinal Drugs Manufacturer (Revenue) Market Share in 2021
    Figure 22. Top 6 Prescription Gastrointestinal Drugs Manufacturer (Revenue) Market Share in 2021
    Figure 23. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2017-2028)
    Figure 24. Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2017-2028)
    Figure 25. North America Prescription Gastrointestinal Drugs Revenue (2017-2028) & (USD Million)
    Figure 26. Europe Prescription Gastrointestinal Drugs Revenue (2017-2028) & (USD Million)
    Figure 27. Asia-Pacific Prescription Gastrointestinal Drugs Revenue (2017-2028) & (USD Million)
    Figure 28. South America Prescription Gastrointestinal Drugs Revenue (2017-2028) & (USD Million)
    Figure 29. Middle East & Africa Prescription Gastrointestinal Drugs Revenue (2017-2028) & (USD Million)
    Figure 30. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
    Figure 31. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2017-2028)
    Figure 32. Global Prescription Gastrointestinal Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 33. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
    Figure 34. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2017-2028)
    Figure 35. Global Prescription Gastrointestinal Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 36. North America Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
    Figure 37. North America Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
    Figure 38. North America Prescription Gastrointestinal Drugs Sales Market Share by Country (2017-2028)
    Figure 39. North America Prescription Gastrointestinal Drugs Revenue Market Share by Country (2017-2028)
    Figure 40. United States Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Canada Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Mexico Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Europe Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
    Figure 44. Europe Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
    Figure 45. Europe Prescription Gastrointestinal Drugs Sales Market Share by Country (2017-2028)
    Figure 46. Europe Prescription Gastrointestinal Drugs Revenue Market Share by Country (2017-2028)
    Figure 47. Germany Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. France Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. United Kingdom Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Russia Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Italy Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Asia-Pacific Prescription Gastrointestinal Drugs Sales Market Share by Region (2017-2028)
    Figure 53. Asia-Pacific Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
    Figure 54. Asia-Pacific Prescription Gastrointestinal Drugs Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Prescription Gastrointestinal Drugs Revenue Market Share by Region (2017-2028)
    Figure 56. China Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Korea Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
    Figure 63. South America Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
    Figure 64. South America Prescription Gastrointestinal Drugs Sales Market Share by Country (2017-2028)
    Figure 65. South America Prescription Gastrointestinal Drugs Revenue Market Share by Country (2017-2028)
    Figure 66. Brazil Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Argentina Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2028)
    Figure 69. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2028)
    Figure 70. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Region (2017-2028)
    Figure 71. Middle East & Africa Prescription Gastrointestinal Drugs Revenue Market Share by Region (2017-2028)
    Figure 72. Turkey Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Egypt Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. South Africa Prescription Gastrointestinal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Manufacturing Cost Structure Analysis of Prescription Gastrointestinal Drugs in 2021
    Figure 77. Manufacturing Process Analysis of Prescription Gastrointestinal Drugs
    Figure 78. Prescription Gastrointestinal Drugs Industrial Chain
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AstraZeneca
Axcan Pharmaceuticals
Eisai
GlaxoSmithKline
Merck
Salix Pharmaceuticals

Related Reports

Global Prescription Gastrointestinal Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Prescription Gastrointestinal Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 29 Jan 2021

date Pharma & Healthcare

The Prescription Gastrointestinal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Prescription Gastrointestinal Drugs Supply, Demand and Key Producers, 2023-2029

Global Prescription Gastrointestinal Drugs Supply, Demand and Key Producers, 2023-2029

date 27 Feb 2023

date Pharma & Healthcare

The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders.

Global Prescription Gastrointestinal Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Prescription Gastrointestinal Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 03 Jan 2023

date Pharma & Healthcare

Global Prescription Gastrointestinal Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Prescription Gastrointestinal Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Prescription Gastrointestinal Drugs market size was valued at USD 29640 million in 2023 and is forecast to a readjusted size of USD 42180 million by 2030 with a CAGR of 5.2% during review period.

Product Tags

prescription gastrointestinal drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>